United Arab Emirates, Dubai: Gone are the days when healthcare solely focused on diagnosis and treatments. Today, hospitals and medical centers around the world aim to establish a standard of care that provides a real-world view of clinical practice, patient outcomes, safety and comparative effectiveness. The patient registry is one such model that can help physicians, and other healthcare providers, access patient information in addition to serving as an integrative method to follow up on patient’s treatment outcomes.
“While the patient registry is a database that is created for the sole purpose of collecting secondary data related to patients with a specific diagnosis or condition, Emirates Integra Medical and Surgery Centre intends to use this standard to map a patient’s entire care journey. This cutting-edge use of the patient registry data will promote informed decision-making and population health management. Ultimately, healthcare professionals know that what matters most is the patients’ ability to achieve their desired outcomes and live free of limitations,” stated Emirates Integra CEO and Chief Science Officer for Emirates Healthcare, Dr. William Murrell.
“We have more than 450 patients registered, and their unique treatments are actively followed. While patient registry is a common system, we adopt a fully proven best practice approach and use it for data collection and analysis in partnership with an existing program called, Standardized Orthopedic Clinical Research and Treatment Evaluation Software (SOCRATES), customized for our clinical needs,” said Kholoud Hafsi, Research Assistant and Patient Educator at Emirates Integra Medical and Surgery Centre, while addressing conference attendees.
Kholoud was selected as one of the keynote speakers to share insights and information about Emirates Integra Medical and Surgery Centre’s unique patient registry system, a practice that helps establish high quality, evidence-based data within the limitations of a rapidly-evolving area.
Per expert analysts, the global patient registry software market is estimated to register an overall valuation of US$2.0 bn by 2023, and is expected to grow at a healthy CAGR of 10.5 percent during the forecast period ranging from 2015 to 2023. Factors that drive the growth of the patient registry software market are:
- An increase in use of electronic health records (EHRs), increase in prevalence of chronic disorders
- Growth in usage of the stored data for post-marketing surveillance
- A surge in healthcare initiatives to build patient registries.
“One of the main reasons we implemented the registry is that Emirates Integra Medical and Surgery Centre is one of the few worldwide facilities that perform stem cell and cellular based therapies. Integrating the registry was an effort to track the safety and outcomes of the use of these cellular technologies, as well as to treat common orthopaedic conditions. The outcomes that the registry system has offered for cellular treatments so far, have been encouraging. The positive results have driven us further to support the Dubai Healthcare City vision to adopt and implement innovative technologies, which position us as a global leader in the healthcare landscape,” added Kholoud.
-Ends-
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
